Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age

Sanjeev Man Bijukchhe; Meeru Gurung; Bhishma Pokhrel; Mila Shakya; Dikshya Pant; Pratistha Maskey; Himang Man Singh Maskey; Babita Dhakal; Shristy Rajkarkinar; Sabitri Bista; Merryn Voysey; Yama F Mujadidi; Young Chan Kim; Rachel Atherton; Elizabeth Jones; Florence McLean; Sonu Shrestha; Matilda Hill; Katherine Theiss Nyland; Sarah Kelly; Peter O’Reilly; Ganesh Prasad Sah; Buddha Basnyat; Andrew J. Pollard; Shrijana Shrestha

doi:10.1016/j.vaccine.2024.02.010

Abstract

Previously, the Vi-typhoid conjugate vaccine (Vi-TT) was found to be highly efficacious in Nepalese children under 16 years of age. We assessed the immunogenicity of Vi-TT at 9 and 12 months of age and response to a booster dose at 15 months of age.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bijukchhe et al. (2024) studied this question.

synapsesocial.com/papers/68e780ceb6db6435876f3d1a https://doi.org/10.1016/j.vaccine.2024.02.010

View Full Paper

Ask AI

Bookmark

Share

Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age

Abstract

Discussion

Cite This Study

Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age

Abstract

Discussion

Cite This Study

Keep reading

Keep reading